United States · 
What does HealthpointCapital invest in?
HealthpointCapital invests most often at Series B and Venture (100% of the rounds on record), in sectors such as Medical Device, In Vitro Diagnostics and Robotics.
HealthpointCapital highlights
- 01
1 cheques in the last 12 months
- 02
Mostly Series B and Venture: 100% of its rounds
- 03
Sole investor in 1 rounds, median undisclosed
What they do
The leading private equity firm in Musculoskeletal HealthcareFrom their own website
- Type
- Private equity (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- Medical DeviceIn Vitro DiagnosticsRobotics
- Based in
- San Diego, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first4 appearances
- 2026
1 round
- Oct
- 2014
1 round
- Jan
- 2013
1 round
- May
- 2012
1 round
- Apr
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration6 named
GDGary Donald StevensonManaging DirectoriForm ADV
JHJohn Hallett FosterExecutive OfficeriFiling they signed
LPLaing P. RikkersExecutive OfficeriFiling they signed
MPMichael Paul MogulFinders' fees, if any, to be paid by management company, not Issuer.iFiling they signed
MTMilen Todorov TodorovExecutive OfficeriFiling they signed
WSWilliam Stanley JohnsonManaging Director / CFO / CCOiForm ADV
We also hold 18 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$271Massets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- Healthpointcapital Management, LLC
- SEC number
- CRD 309041
Funds on its Form ADV
2 private funds, $181M in gross assets · filed Mar 2024
- HealthpointCapital Musculoskeletal Fund II, L.P.Private equity89 investors$132M
- HealthpointCapital Partners IV, L.P.Private equity83 investors$49M
What they claim to have backed
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Companies it bought
Acquisitions by the firm itself
Bio-Lok InternationalUndisclosedOct 2006